NASDAQ
MediPharm Labs Corp. (MEDIF) has a free cash flow growth of -264.56% as of Friday, May 29, 2026. This represents a 453.16% decrease compared to its 12-month average of 74.91%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.